LIHUI QIN, MD
Medical Practice at 68 St, New York, NY

License number
New York 041858
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
525 E 68Th St, New York, NY 10065
Phone
(212) 746-1676

Personal information

See more information about LIHUI QIN at radaris.com
Name
Address
Phone
Lihui Qin
1391 Madison Ave, New York, NY 10029

Professional information

Lihui Qin Photo 1

Dr. Lihui Qin, New York NY - MD (Doctor of Medicine)

Specialties:
Anatomic Pathology
Address:
525 E 68Th St, New York 10065
(212) 746-1676 (Phone), (212) 746-8624 (Fax)
20 York St SUITE 2608, New Haven 06510
(203) 785-3624 (Phone), (203) 785-7037 (Fax)
YALE NEW HAVEN HOSPITAL
20 York St, New Haven 06510
(203) 785-4025 (Phone), (203) 785-7053 (Fax)
YNHH-PSYCHIATRY
20 York St, New Haven 06510
(888) 946-4658 (Phone), (203) 737-2221 (Fax)
Certifications:
Anatomic Pathology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
525 E 68Th St, New York 10065
20 York St SUITE 2608, New Haven 06510
YALE NEW HAVEN HOSPITAL
20 York St, New Haven 06510
YNHH-PSYCHIATRY
20 York St, New Haven 06510
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Beijing Medical University
Graduated: 1986


Lihui Qin Photo 2

Immunosuppressive Structural Definition Of Il-10

US Patent:
6428985, Aug 6, 2002
Filed:
Nov 30, 1999
Appl. No.:
09/452624
Inventors:
Jonathan S. Bromberg - New York NY
YaoZhong Ding - Forest Hills NY
LiHui Qin - New York NY
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12P 2100
US Classification:
435 6952, 435 691, 435 695, 435440, 435445, 530351, 5303873, 536 235, 536 2352, 536 2372, 536 231, 514 2, 514 8, 514 12
Abstract:
Disclosed is the surprising discovery that a single amino acid provides the demarcation between the immunosuppressive and immunostimulatory properties of the cytokine, IL-10. The present invention thus provides mammalian and human IL-10 genes and polypeptides that have immunosuppressive properties, without immunostimulatory side-effects. Also provided are various methods of using the new IL-10 constructs, both in vitro and in vivo, particularly in sole or combination therapies involving immunosuppression, such as in the treatment of inflammatory diseases and disorders, and in transplantation.